Development of an experimental human blood-stage model for studying Plasmodium knowlesi
Open Access
- 22 April 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (3) , e652-e660
Abstract
Background: The zoonotic parasite Plasmodium knowlesi is an increasing cause of human malaria in Southeast Asia. We aimed to develop a P. knowlesi induced blood-stage malaria (IBSM) model to facilitate study of parasite biology, host responses to infection, and activity of antimalarial treatments. Methods: We manufactured and characterised a P. knowlesi parasite bank using the P. knowlesi YH1 strain adapted to grow in human serum. This P. knowlesi bank was evaluated in an IBSM study involving four adults intravenously inoculated with P. knowlesi-infected erythrocytes using a dose escalation strategy (10-fold increases from ∼2,800 parasites). Parasitaemia was monitored by qPCR. All participants received curative treatment with artemether-lumefantrine. Endpoints included safety and infectivity of the P. knowlesi bank. Results: Two of the four participants developed detectable parasitaemia. Participant two (administered ∼28,000 parasites) had detectable parasites (∼6 parasites/mL) immediately prior to protocol-defined treatment on day 21. Participant three (administered ∼280,000 parasites) developed detectable parasites on day 17, peaking at 202 parasites/mL just after protocol-defined treatment on day 24; the parasite multiplication rate over 32 hours (PMR32) was 2.33 (95% CI 1.66-3.25). Participant four (also administered ∼280,000 parasites) did not become infected. Adverse events were mostly mild and unrelated to the challenge agent. Conclusions: A GMP-grade P. knowlesi YH1-HS parasite bank was successfully manufactured and shown to establish patent infection in humans. The finding that only one of two participants became infected at the highest inoculum dose highlights the potential for this IBSM model to evaluate factors influencing inter-individual variability in susceptibility to infection.Keywords
Funding Information
- National Health and Medical Research Council (2016792)
- Royal Australasian College of Physicians
- Royal Brisbane and Women's Hospital Foundation
- Snow Medical (2022/SF167)
- CSL Centenary Fellowship
- NHMRC Investigator Grant (2017436)
- Medicines for Malaria Venture
This publication has 31 references indexed in Scilit:
- Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection studyThe Lancet Infectious Diseases, 2024
- Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection studyThe Lancet Infectious Diseases, 2022
- Age-Related Clinical Spectrum of Plasmodium knowlesi Malaria and Predictors of SeverityClinical Infectious Diseases, 2018
- PacBio assembly of aPlasmodium knowlesigenome sequence with Hi-C correction and manual annotation of theSICAvargene familyParasitology, 2017
- Individual-level factors associated with the risk of acquiring human Plasmodium knowlesi malaria in Malaysia: a case-control studyThe Lancet Planetary Health, 2017
- Plasmodium vivax Controlled Human Malaria Infection – Progress and ProspectsTrends in Parasitology, 2017
- Experimentally Induced Blood-Stage Plasmodium vivax Infection in Healthy VolunteersThe Journal of Infectious Diseases, 2013
- Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humansNature Communications, 2013
- A Prospective Comparative Study of Knowlesi, Falciparum, and Vivax Malaria in Sabah, Malaysia: High Proportion With Severe Disease From Plasmodium Knowlesi and Plasmodium Vivax But No Mortality With Early Referral and Artesunate TherapyClinical Infectious Diseases, 2012
- Proteomic studies of Plasmodium knowlesi SICA variant antigens demonstrate their relationship with P. falciparum EMP1Infection, Genetics and Evolution, 2006